Efficacy and Safety of Ublituximab vs Teriflunomide in Patients with Relapsing Multiple Sclerosis: Results from Two Phase 3 Studies ULTIMATE I & ULTIMATE II American Academy of Neurology

Drug Category: Array
Conference Category: Array
Lead Author: Steinman L, et al.
Published Date: 17/04/2021
Download Link: /wp-content/uploads/2021/04/ULTIMATE-I-II-Phase-3-Poster-AAN-2021.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top